Veterans with ALS Reporting Act
- Bill Number
- H.R. 6001
- Origin Chamber
- House
- Congress
- 119th Congress, Session 1
- Policy Area
- Armed Forces and National Security
- Status
- Introduced
- Latest Action
- 2026-04-16: Forwarded by Subcommittee to Full Committee by Voice Vote.
- Last Updated
- 2026-04-17T08:07:17Z
AI-Generated Summary
Purpose
The legislation, titled the "Veterans with ALS Reporting Act," aims to address the higher rates of amyotrophic lateral sclerosis (ALS, a progressive neurodegenerative disease that affects nerve cells in the brain and spinal cord) among veterans by requiring the Department of Veterans Affairs (VA) to report on its prevalence, available support, and strategies to reduce risks. It seeks to improve tracking, resources, and research participation for veterans with ALS.
Key Provisions
- Initial Report Requirement: Within one year of enactment, the VA Secretary, in consultation with the Director of the Centers for Disease Control and Prevention (CDC), must submit a comprehensive report to Congress. This report includes:
- An assessment of ALS incidence (new cases) and prevalence (existing cases) among veterans, defined under federal law as individuals who served in the U.S. military.
- A description of resources and support provided by the CDC and VA to veterans with ALS, such as medical care, financial aid, or research programs.
- Identification of any gaps or shortcomings in these resources and support.
- A strategy to develop and test methods to reduce ALS risks specifically for veterans, potentially including environmental or lifestyle factors linked to military service.
- A plan to create pathways for veterans receiving ALS care at VA clinics to join VA-sponsored clinical trials (research studies testing new treatments) and other studies.
- Recommendations for new laws to tackle challenges in lowering ALS rates among veterans.
- Tracking Mechanism: The VA must monitor ALS prevalence in veterans using the CDC's existing ALS registry (a database of cases) and biorepository (a collection of biological samples for research).
- Ongoing Updates: Every three years after enactment, starting three years from the date, the VA must provide Congress with an updated report incorporating new data on prevalence and progress on the initial strategies.
Significant Changes to Existing Law
This bill introduces new mandates for the VA, including the first formal requirement for a detailed congressional report on ALS in veterans and periodic updates. It builds on existing CDC tools like the ALS registry but expands VA's role in using them for veteran-specific tracking. Previously, while the VA provides ALS benefits (e.g., disability compensation presuming service connection for certain veterans), there was no statutory obligation for such comprehensive risk reduction planning or research pathway development.
Potential Impacts
- Government Agencies: The VA and CDC will face increased administrative and research workloads, including data collection, strategy development, and reporting, which may require additional funding or staff. This could enhance inter-agency collaboration on veteran health.
- Citizens (Veterans): Veterans with ALS or at risk may benefit from improved access to clinical trials, better-targeted support, and potential reductions in disease rates through risk strategies. It could lead to more equitable healthcare and research opportunities within the VA system.
- International Relations: No direct impacts, as the bill focuses on domestic U.S. veteran health and does not involve foreign policy or global health initiatives.
Main Stakeholders Affected
- Veterans: Particularly those diagnosed with or at risk for ALS, who may gain from enhanced monitoring, support, and research access.
- Department of Veterans Affairs (VA): Responsible for implementing reporting, tracking, and strategy development.
- Centers for Disease Control and Prevention (CDC): Provides consultation and tools like the ALS registry, potentially expanding its role in veteran-specific data.
- Congress: Receives reports to inform future legislation and oversight of veteran health programs.
- Veterans' Advocacy Groups: Organizations supporting ALS patients may use the reports to advocate for more resources.
Notable Legal, Constitutional, or Political Implications
- Legal: Strengthens the VA's accountability under Title 38 of the U.S. Code (governing veterans' benefits) by mandating data-driven strategies, potentially setting precedents for addressing other service-related diseases. It does not create new entitlements but could influence future benefit expansions based on report recommendations.
- Constitutional: Aligns with Congress's authority to regulate military benefits and public health (under Article I), with no apparent conflicts involving individual rights or federalism.
- Political: Highlights bipartisan concern for veteran health (introduced by members from both parties), potentially increasing focus on ALS research funding. It may spur debates on military environmental exposures (e.g., toxins) as ALS risk factors, influencing broader defense and health policy without partisan bias in the bill itself.
This summary was generated by AI and may contain inaccuracies. Refer to the official source document for the authoritative text.
Sponsor
Cosponsors (9)
Rep. Calvert, Ken [R-CA-41], Rep. Sewell, Terri A. [D-AL-7], Rep. Fitzpatrick, Brian K. [R-PA-1], Rep. Quigley, Mike [D-IL-5], Rep. Bell, Wesley [D-MO-1], Rep. Riley, Josh [D-NY-19], Rep. Harshbarger, Diana [R-TN-1], Rep. McBride, Sarah [D-DE-At Large], Rep. Johnson, Julie [D-TX-32]
Recent Actions
- 2026-04-16: Forwarded by Subcommittee to Full Committee by Voice Vote.
- 2026-04-16: Subcommittee Consideration and Mark-up Session Held
- 2026-01-13: Subcommittee Hearings Held
- 2025-11-17: Referred to the Subcommittee on Health.
- 2025-11-10: Referred to the House Committee on Veterans' Affairs.
- 2025-11-10: Introduced in House
- 2025-11-10: Introduced in House
Bill Versions
- Veterans with ALS Reporting Act — issued 2025-11-10 — PDF (3 pages)